Expression of a Recombinant Toxoplasma gondii ROP2 Fragment as a Fusion Protein in Bacteria Circumvents Insolubility and Proteolytic Degradation-Reference-Cited by-同舟云学术

Expression of a Recombinant Toxoplasma gondii ROP2 Fragment as a Fusion Protein in Bacteria Circumvents Insolubility and Proteolytic Degradation

Published:1999-12 Issue:3 Volume:17 Page:392-400
ISSN:1046-5928
Container-title:Protein Expression and Purification
language:en
Short-container-title:Protein Expression and Purification

Author:

Jacquet Alain,Daminet Véronique,Haumont Michèle,Garcia Lida,Chaudoir Sylvie,Bollen Alex,Biemans Ralph

Publisher

Elsevier BV

Subject

Biotechnology

Reference22 articles.

1. Toxoplasmosis in the non-AIDS-immunocompromised host;Israelski;Curr. Clin. Top. Infect. Dis.,1993

2. Toxoplasmosis in pregnancy;Wong;Clin. Infect. Dis.,1994

3. Toxoplasmosis encephalitis in AIDS;Luft;Clin. Infect. Dis.,1992

4. Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-γ production and protective immunity induced by an attenuated Toxoplasma gondii vaccine;Gazzinelli;J. Immunol.,1991

5. Interferon-γ: The major mediator of resistance against Toxoplasma gondii;Suzuki;Science,1988

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single Cell Expression Systems for the Production of Recombinant Proteins for Immunodiagnosis and Immunoprophylaxis of Toxoplasmosis;Microorganisms;2024-08-22

2. Corrigendum: The main protease 3CLpro of the SARS-CoV-2 virus: how to turn an enemy into a helper;Frontiers in Bioengineering and Biotechnology;2023-11-06

3. The main protease 3CLpro of the SARS-CoV-2 virus: how to turn an enemy into a helper;Frontiers in Bioengineering and Biotechnology;2023-06-29

4. Predictive approaches to guide the expression of recombinant vaccine targets in Escherichia coli: a case study presentation utilising Absynth Biologics Ltd. proprietary Clostridium difficile vaccine antigens;Applied Microbiology and Biotechnology;2021-06-28

5. Recombinant Enterovirus 71 Viral Protein 1 Fused to a Truncated Newcastle Disease Virus NP (NPt) Carrier Protein;Vaccines;2020-12-07